Abstract
Similar to the other neurotrophic factors, the glial cell line-derived neurotrophic factor (GDNF) may inhibit apoptosis in vitro. However, the antiapoptotic GDNF effects in vivo are not known. We studied the effect of GDNF central administration of on the mRNA levels of genes encoding the proapoptotic protein Bax and the antiapoptotic protein Bcl-xl in the brain of ASC mice genetically predisposed to depressivelike behavior and mice of their nondepressive parental CBA strain. We found that the GDNF injection increased the Bcl-xl mRNA content in the hippocampi of mice of both strains (ρ < 0.05) and Bax mRNA (ρ < 0.05) in the hippocampus of ASC mice. Thus, we revealed both the antiand proapoptotic effects of GDNF in vivo. These effects substantially depended on the genotype of the animals. We also observed significant interstrain differences in the Bax and Bcl-xl mRNA levels. In ASC mice, the Bax mRNA levels were significantly higher (ρ < 0.001 and ρ < 0.01) in all investigated structures and the content of Bcl-xl mRNA was elevated in the midbrain. Our data demonstrate the activation of apoptotic processes in ASC mice and the substantial compensatory changes, probably directed to the rise of the threshold for neuronal apoptosis.
Similar content being viewed by others
References
Anisman, H., Cascading effects of stressors and inflammatory immune system activation: implications for major depressive disorder, J. Psychiatry Neurosci., 2009, vol. 34, pp. 4–20.
Buisson, A., Lesne, S., Docagne, F., Ali, C., and Nicole, O., Mackenzie, E.T., and Vivien, D., Transforming growth factor-beta and ischemic brain injury, Cell Mol. Neurobiol., 2003, vol. 23, nos 4/5, pp. 539–550.
Campbell, S. and Macqueen, G., An update on regional brain volume differences associated with mood disorders, Curr. Opin. Psychiatry, 2006, vol. 19, no. 1, pp. 25–33.
Cao, J.P., Niu, H.Y., Wang, H.J., Huang, X.G., and Gao, D.S., NF-κB p65/p52 plays a role in GDNF upregulating Bcl-2 and Bcl-w expression in 6-OHDAinduced apoptosis of MN9D cell, Int. J. Neurosci., 2013, vol. 123, no. 10, pp. 705–710.
Chao, C.C., Ma, Y.L., and Lee, E.H., Brain-derived neurotrophic factor enhances Bcl-xL expression through protein kinase casein kinase 2-activated and nuclear factor kappa B-mediated pathway in rat hippocampus, Brain Pathol., 2011, vol. 21, no. 2, pp. 150–162.
Chen, S.J., Kao, C.L., Chang, Y.L., Yen, C.J., Shui, J.W., Chien, C.S., Chen, I.L., Tsai, T.H., Ku, H.H., and Chiou, S.H., Antidepressant administration modulates neural stem cell survival and serotoninergic differentiation through bcl-2, Curr. Neurovasc. Res., 2007, vol. 4, no. 1, pp. 19–29.
Chiou, S.H., Ku, H.H., Tsai, T.H., Lin, H.L., Chen, L.H., Chien, C.S., Ho, L.L., Lee, C.H., and Chang, Y.L., Moclobemide upregulated Bcl-2 expression and induced neural stem cell differentiation into serotoninergic neuron via extracellular-regulated kinase pathway, Br. J. Pharmacol., 2006, vol. 148, no. 5, pp. 587–598.
Duman, R.S. and Aghajanian, G.K., Synaptic dysfunction in depression: potential therapeutic targets, Science, 2012, vol. 1, no. 6103, pp. 68–72.
Dygalo, N.N., Kalinina, T.S., Bulygina, V.V., and Shishkina, G.T., Increased expression of the anti-apoptotic protein in the brain is associated with resilience to stress-induced depression-like behavior, Cell. Mol. Neurobiol., 2012, vol. 32, no. 5, pp. 767–76.
Hoshaw, B.A., Malberg, J.E., and Lucki, I., Central administration of IGF-I and BDNF leads to long-lasting antidepressant-like effects, Brain Res., 2005, vol. 1, pp. 204–208.
Kim, R., Unknotting the roles of bcl-2 and bcl-xl in cell death, Biochem. Biophys. Res. Commun., 2005, vol. 333, no. 2, pp. 336–343.
Kim, H.R., Heo, Y.M., Jeong, K.I., Kim, Y.M., Jang, H.L., Lee, K.Y., Yeo, C.Y., Kim, S.H., Lee, H.K., Kim, S.R., Kim, E.G., and Choi, J.K., FGF-2 inhibits TNF-2 mediated apoptosis through upregulation of Bcl2-A1 and Bcl-xL in ATDC5 cells, BMB Rep., 2012, vol. 45, no. 5, pp. 287–292.
Kosten, T.A., Galloway, M.P., Duman, R.S., Russell, D.S., and D’Sa, C., Repeated unpredictable stress and antidepressants differentially regulate expression of the Bcl-2 family of apoptotic genes in rat cortical, hippocampal, and limbic brain structures, Neuropsychopharmacology, 2008, vol. 33, pp. 1545–1558.
Kubera, M., Obuchowicz, E., Goehler, L., Brzeszcz, J., and Maes, M., In animal models, psychosocial stressinduced (neuro) inflammation, apoptosis and reduced neurogenesis are associated to the onset of depression, Prog. Neuropsychopharmacol. Biol. Psychiatry, 2011, vol. 35, no. 3, pp. 744–759.
Kulikov, A.V., Bazovkina, D.V., Kondaurova, E.M., and Popova, N.K., Genetic structure of hereditary catalepsy in mice, Genes Brain Behav., 2008, vol. 7, pp. 506–512.
Liu, Q., Zhu, H.Y., Li, B., Wang, Y.Q., Yu, J., and Wu, G.C., Chronic clomipramine treatment restores hippocampal expression of glial cell line-derived neurotrophic factor in a rat model of depression, J. Affect. Disord., 2012, vol. 141, nos. 2/3, pp. 367–372.
Maes, M., The cytokine hypothesis of depression: inflammation, oxidative and nitrosative stress (io&ns) and leaky gut as new targets for adjunctive treatments in depression, Neuro. Endocrinol. Lett, 2008, vol. 29, no. 3, pp. 287–291.
Maes, M., Galecki, P., Chang, Y.S., and Berk, M., A review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro) degenerative processes in that illness, Prog. Neuropsychopharmacol. Biol. Psychiatry, 2011, vol. 35, no. 3, pp. 676–692.
Miller, A.H., Maletic, V., and Raison, C.L., Inflammation and its discontents: the role of cytokinesin in the pathophysiology of major depression, Biol. Psychiatry, 2009, vol. 65, pp. 732–741.
Mogi, M., Kondo, A., Kinpara, K., and Togari, A., Antiapoptotic action of nerve growth factor in mouse osteoblastic cell line, Life Sci., 2000, vol. 67, no. 10, pp. 1197–1206.
Moylan, S., Maes, M., Wray, N.R., and Berk, M., The neuroprogressive nature of major depressive disorder: pathways to disease evolution and resistance, and therapeutic implications, Mol. Psychiatry, 2013, vol. 18, no. 5, pp. 595–606.
Naumenko, V.S. and Kulikov, A.V., Quantitative assay of 5ht(1a) serotonin receptor gene expression in the brain, Mol. Biol. (Mosc.), 2006, vol. 40, no. 1, pp. 37–44.
Naumenko, V.S., Osipova, D.V., Kostina, E.V., and Kulikov, A.V., Utilization of a two-standard system in real-time pcr for quantification of gene expression in the brain, J. Neurosci. Methods, 2008, vol. 170, pp. 197–203.
Naumenko, V.S., Kondaurova, E.M., Bazovkina, D.V., Tsybko, A.S., Tikhonova, M.A., Kulikov, A.V., and Popova, N.K., Effect of brain-derived neurotrophic factor on behavior and key members of the brain serotonin system in genetically predisposed to behavioral disorders mouse strains, Neuroscience, 2012, vol. 1, pp. 59–67.
Naumenko, V.S., Bazovkina, D.V., Semenova, A.A., Tsybko, A.S., Il’chibaeva, T.V., Kondaurova, E.M., and Popova, N.K., Effect of glial cell line-derived neurotrophic factor on behavior and key members of the brain serotonin system in mouse strains genetically predisposed to behavioral disorders, J. Neurosci. Res., 2013, vol. 91, no. 12, pp. 1628–1638.
Oo, T.F., Kholodilov, N., and Burke, R.E., Regulation of natural cell death in dopaminergic neurons of the substantia nigra by striatal glial cell line-derived neurotrophic factor in vivo, J. Neurosci., 2003, vol. 23, no. 12, pp. 5141–5148.
Peterson, A.L. and Nutt, J.G., Treatment of Parkinson’s disease with trophic factors, Neurotherapeutics, 2008, vol. 5, no. 2, pp. 270–280.
Semenova, A.A., Bazovkina, D.V., and Tsybko, A.S., Naumen-ko V.S., Popova N.K. Effect of GDNF on the behavior of mice ASC with a high genetic predisposition to catalepsy, Zh. Vyssh. Nervn. Deyat. im. I.P. Pavlova, 2013, vol. 63, pp. 495–501.
Semenova, A.A., Bazovkina, D.V., Tsybko, A.S., Naumenko, V.S., and Popova, N.K., Effect of GDNF on the behavior of ASC mice with high hereditary predisposition to catalepsy, Zh. Vyssh. Nerv. Deiat. Im. I.P. Pavlova, 2013, vol. 63, no. 4, pp. 495–501.
Shirayama, Y., Chen, A.C., Nakagawa, S., Russell, D.S., and Duman, R.S., Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression, J. Neurosci., 2002, vol. 22, pp. 3251–3261.
Shishkina, G.T., Kalinina, T.S., Berezova, I.V., and Dygalo, N.N., Stress-induced activation of the brainstem Bcl-xL gene expression in rats treated with fluoxetine: correlations with serotonin metabolism and depressive-like behavior, Neuropharmacology, 2012, vol. 62, no. 1, pp. 177–183.
Siuciak, J.A., Lewis, D.R., Wiegand, S.J., and Lindsay, R.M., Antidepressant-like effect of brain-derived neurotrophic factor (BDNF), Pharmacol. Biochem. Behav., 1997, vol. 56, pp. 131–137.
Slotnick, B.M. and Leonard, C.M., A Stereotaxic Atlas of the Albino Mouse Forebrain. Rockville, Maryland: U.S. Dept. of Health, Education and Welfare, 1975.
Taylor, H., Barua, N., Bienemann, A., Wyatt, M., Castrique, E., Foster, R., Luz, M., Fibiger, C., Mohr, E., and Gill, S., Clearance and toxicity of recombinant methionyl human glial cell line-derived neurotrophic factor (r-metHu GDNF) following acute convectionenhanced delivery into the striatum, PLoS One, 2013, vol. 8, no. 3, p. e56186.
Tikhonova, M.A., Kulikov, A.V., Bazovkina, D.V., Kulikova, E.A., Tsybko, A.S., Bazhenova, E.Y., Naumenko, V.S., Akulov, A.E., Moshkin, M.P., and Popova, N.K., Hereditary catalepsy in mice is associated with the brain dysmorphology and altered stress response, Behav. Brain Res., 2013, vol. 243, pp. 53–60.
Youle, R.J. and Strasser, A., The BCL-2 protein family: opposing activities that mediate cell death, Nat. Rev. Mol. Cell. Biol., 2008, vol. 9, no. 1, pp. 47–59.
Author information
Authors and Affiliations
Corresponding author
Additional information
Original Russian Text © A.S. Tsybko, T.V. Il’chibaeva, V.S. Naumenko, 2014, published in Vavilovskii Zhurnal Genetiki i Selektsii, 2014, Vol. 18, No. 4/3, pp. 1110–1116.
Rights and permissions
About this article
Cite this article
Tsybko, A.S., Il’chibaeva, T.V. & Naumenko, V.S. The effects of the glial cell line-derived neurotrophic factor (GDNF) on the levels of mRNA of apoptotic genes Bax and Bcl-xl in the brain of mice genetically predisposed to pathological behavior. Russ J Genet Appl Res 5, 407–412 (2015). https://doi.org/10.1134/S2079059715040152
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S2079059715040152